Clinical Trial Update: Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for non-myeloablative allogeneic transplantation using TLI and ATG in patients with cutaneous T-cell lymphoma shows completed stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Transplant Failure
• Cutaneous T-cell Lymphoma
• Lymphoma Non-hodgkin
• Lymphoma T-cell Cutaneous
• Mycoses
• Sezary Syndrome

Snippet

Sponsor: Stanford University | Conditions: Mycoses, Sezary Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2023-05-11